Follicular lymphoma

1 paper

Human trial1

Trial sponsors

Celgene
Company4 trialsPhase 3616 people
Genmab
Company3 trialsPhase 31,716 people
Pharmacyclics
Company3 trialsPhase 3586 people
Regeneron
Company2 trialsPhase 31,555 people
MEI Pharma
Company2 trialsPhase 3166 people
Janssen Research & Development
Company1 trialPhase 3539 people
Celltrion
Company1 trialPhase 3140 people
Novartis Pharmaceuticals Corporation
Company1 trialPhase 3109 people

Latest

Leukemia7 Dec

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Non-randomised trial in 77 peoplemTOR inhibitors